Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Provention Bio (PRVB) News Today

Provention Bio logo
Macrogenics Inc MGNX
Provention Bio, Inc. stock logo
Cambridge Investment Research Advisors Inc. Increases Stock Holdings in Provention Bio, Inc. (NASDAQ:PRVB)
Cambridge Investment Research Advisors Inc. boosted its position in shares of Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) by 86.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,895 shares of the company's stock af
Provention Bio, Inc. stock logo
Provention Bio, Inc. (NASDAQ:PRVB) Stock Holdings Increased by Swiss National Bank
Swiss National Bank raised its holdings in shares of Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) by 47.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 187,100 shares of the company's stock af
Provention Bio, Inc. stock logo
Arizona State Retirement System Purchases 7,068 Shares of Provention Bio, Inc. (NASDAQ:PRVB)
Arizona State Retirement System increased its position in Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) by 47.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,860 shares of the company's stock after buying an ad
Provention Bio, Inc. stock logo
SG Americas Securities LLC Purchases New Position in Provention Bio, Inc. (NASDAQ:PRVB)
SG Americas Securities LLC acquired a new position in shares of Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 10,354 shares of the company's stock, valued at approximately $109,000. Several other large investo
Provention Bio, Inc. stock logo
Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Holdings in Provention Bio, Inc. (NASDAQ:PRVB)
Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) by 169.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,427 share
Provention Bio, Inc. stock logo
Provention Bio, Inc. (NASDAQ:PRVB) Given Consensus Rating of "Hold" by Brokerages
Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) has earned an average recommendation of "Hold" from the seven research firms that are presently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy ratin
Provention Bio, Inc. stock logo
Provention Bio, Inc. (NASDAQ:PRVB) Shares Purchased by New York State Common Retirement Fund
New York State Common Retirement Fund increased its position in shares of Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) by 28.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 34,909 shares of the company'
Sanofi completes Provention Bio acquisition
PRVB Apr 2023 23.000 put
Provention Bio, Inc. stock logo
Provention Bio, Inc. (NASDAQ:PRVB) Receives Average Recommendation of "Hold" from Analysts
Shares of Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) have received a consensus recommendation of "Hold" from the seven analysts that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the co
Provention Bio, Inc. stock logo
Rice Hall James & Associates LLC Has $1.92 Million Holdings in Provention Bio, Inc. (NASDAQ:PRVB)
Rice Hall James & Associates LLC trimmed its position in Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) by 17.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 181,980 shares of the company's stock a
Provention Bio, Inc. stock logo
Oppenheimer Equities Analysts Cut Earnings Estimates for Provention Bio, Inc. (NASDAQ:PRVB)
Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) - Research analysts at Oppenheimer reduced their FY2023 earnings per share estimates for Provention Bio in a report issued on Wednesday, March 29th. Oppenheimer analyst J. Kim now expects that the company will earn ($1.71) per share for the year, do
Provention Bio, Inc. stock logo
Provention Bio, Inc. (NASDAQ:PRVB) Given Average Recommendation of "Hold" by Analysts
Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) has been assigned a consensus recommendation of "Hold" from the seven research firms that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. The av
Q4 2022 MacroGenics Inc Earnings Call
Provention Bio's Earnings Outlook
Provention Bio, Inc. stock logo
Provention Bio (NASDAQ:PRVB) Earns "Neutral" Rating from Sumitomo Mitsui Financial Group
Sumitomo Mitsui Financial Group restated a "neutral" rating and issued a $25.00 price target (up previously from $15.00) on shares of Provention Bio in a research note on Tuesday.
Short Volatility Alert: Provention Bio Inc
4 Analysts Have This to Say About Provention Bio
Why Is Provention Bio (PRVB) Stock Up 263% Today?
Sanofi To Buy Provention Bio For Around $2.9 Bln In Cash
Provention Bio, Inc. stock logo
Provention Bio (PRVB) Scheduled to Post Quarterly Earnings on Thursday
Provention Bio (NASDAQ:PRVB) will be releasing earnings before the market opens on Thursday, March 16, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=504040)
Provention Bio, Inc. stock logo
390,800 Shares in Provention Bio, Inc. (NASDAQ:PRVB) Purchased by Palo Alto Investors LP
Palo Alto Investors LP purchased a new position in Provention Bio, Inc. (NASDAQ:PRVB - Get Rating) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 390,800 shares of the company's stock, v
Get Provention Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRVB and its competitors with MarketBeat's FREE daily newsletter.

Ever heard of this 8-day bitcoin profit window? (Ad)

Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.

It’s coming up quick.

PRVB Media Mentions By Week

PRVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRVB
News Sentiment

1.56

0.49

Average
Medical
News Sentiment

PRVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRVB Articles
This Week

0

0

PRVB Articles
Average Week

Get Provention Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRVB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PRVB) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners